Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.
复制标题
DOI:
10.1038/nrmicro1927
复制
发表时间:
2008-07
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Virotherapy is currently undergoing a renaissance, based on our improved understanding of virus biology and genetics and our better knowledge of many different types of cancer. Viruses can be reprogrammed into oncolytic vectors by combining three types of modification: targeting, arming and shielding. Targeting introduces multiple layers of cancer specificity and improves safety and efficacy; arming occurs through the expression of prodrug convertases and cytokines; and coating with polymers and the sequential usage of different envelopes or capsids provides shielding from the host immune response. Virus-based therapeutics are beginning to find their place in cancer clinical practice, in combination with chemotherapy and radiation.
登录
查看更多内容
影响因子:
5.4
作者:
Belousova, N;Korokhov, N;Krasnykh, V
通讯作者:
Krasnykh, V
影响因子:
56.9
作者:
Darnell, JE
通讯作者:
Darnell, JE
影响因子:
46.9
作者:
Chase, M;Chung, RY;Chiocca, EA
通讯作者:
Chiocca, EA
影响因子:
5.4
作者:
Croyle, MA;Chirmule, N;Wilson, JM
通讯作者:
Wilson, JM
影响因子:
3.7
作者:
Childs, Kay;Stock, Nicola;Goodbourn, Stephen
通讯作者:
Goodbourn, Stephen